← Open Payments lookup

KRISTINE THOMPSON: Open Payments

NPI 1316057029 · MIDLOTHIAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,281 in 49 payments from 11 companies in 2025. Trend: 2023 $1,071 · 2024 $1,261 · 2025 $2,281

Food & beverage: $2,281
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$438
ABBVIE INC.7$437
Vanda Pharmaceuticals Inc.14$391
E.R. Squibb & Sons, L.L.C.4$364
Otsuka America Pharmaceutical, Inc.9$234
Neurocrine BioSciences, Inc.2$149
Axsome Therapeutics, Inc.1$115
Supernus Pharmaceuticals, Inc.1$96
Collegium Pharmaceutical, Inc.1$20
Teva Pharmaceuticals USA, Inc.1$19

Products named: CAPLYTA, VRAYLAR, FANAPT, COBENFY, REXULTI, INGREZZA, Auvelity, Qelbree.

Industry payments across VA — which companies pay providers there.